Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
Hammersmith Health Books
In STEP 1, participants on 2.4 mg lost an average of 14.9% body weight over 68 weeks compared to 2.4% with placebo
Rybelsus Rybelsus, the oral tablet form of semaglutide, expires two years from the date of manufacture
The adherence challenge is real, but for the patients who tolerate the drugs well and can access them, the data is strong
A landmark 2023 JAMA study found GLP-1 users face significantly elevated risks: 3.67 times higher risk of gastroparesis, 4.22 times higher risk of bowel obstruction, and 9.09 times higher risk of pancreatitis compared to patients using other weight loss medications
We provide a telehealth-first experience where you can access expert medical guidance and high-quality medications without the need for in-person visits or waiting rooms
